» Articles » PMID: 23203277

Effect of Fucoidan Extracted from Mozuku on Experimental Cartilaginous Tissue Injury

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2012 Dec 4
PMID 23203277
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the effect of fucoidan, a sulfated polysaccharide, on acceleration of healing of experimental cartilage injury in a rabbit model. An injured cartilage model was surgically created by introduction of three holes, one in the articular cartilage of the medial trochlea and two in the trochlear sulcus of the distal femur. Rabbits in three experimental groups (F groups) were orally administered fucoidan of seven different molecular weights (8, 50, 146, 239, 330, 400, or 1000 kD) for 3 weeks by screening. Control (C group) rabbits were provided water ad libitum. After the experimental period, macroscopic examination showed that the degree of filling in the fucoidan group was higher than that in the C group. Histologically, the holes were filled by collagen fiber and fibroblasts in the C group, and by chondroblasts and fibroblasts in the F groups. Image analysis of Alcian blue- and safranin O-stained F-group specimens showed increased production of glycosaminoglycans (GAGs) and proteoglycans (PGs), respectively. Some injured holes were well repaired both macroscopically and microscopically and were filled with cartilage tissues; cartilage matrices such as PGs and GAGs were produced in groups F 50, F 146, and F 239. Thus, fucoidan administration enhanced morphologically healing of cartilage injury.

Citing Articles

Marine-Inspired Approaches as a Smart Tool to Face Osteochondral Regeneration.

Tampieri A, Kon E, Sandri M, Campodoni E, Dapporto M, Sprio S Mar Drugs. 2023; 21(4).

PMID: 37103351 PMC: 10145639. DOI: 10.3390/md21040212.


stimulates mesenchymal stem cell differentiation and regenerates cartilage in a rabbit osteoarthritis model.

Sawada Y, Sugimoto A, Osaki T, Okamoto Y Exp Ther Med. 2018; 15(5):4080-4088.

PMID: 29725360 PMC: 5920389. DOI: 10.3892/etm.2018.5981.


Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial.

Myers S, Mulder A, Baker D, Robinson S, Rolfe M, Brooks L Biologics. 2016; 10:81-8.

PMID: 27307702 PMC: 4887044. DOI: 10.2147/BTT.S95165.


Anti-Proliferation Activity of Fucoidan in MKN45 Gastric Cancer Cells and Downregulation of Phosphorylated ASK1, a Cell Cycle-Regulated Kinase.

Yoshimoto M, Higaki K, Nanba E, Ikeguchi M Yonago Acta Med. 2015; 58(1):1-7.

PMID: 26190891 PMC: 4495266.

References
1.
Deal C, Moskowitz R . Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. 1999; 25(2):379-95. DOI: 10.1016/s0889-857x(05)70074-0. View

2.
Maroudas A, Bayliss M, Venn M . Further studies on the composition of human femoral head cartilage. Ann Rheum Dis. 1980; 39(5):514-23. PMC: 1000596. DOI: 10.1136/ard.39.5.514. View

3.
Iovu M, Dumais G, du Souich P . Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 2008; 16 Suppl 3:S14-8. DOI: 10.1016/j.joca.2008.06.008. View

4.
Dodge G, Jimenez S . Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage. 2003; 11(6):424-32. DOI: 10.1016/s1063-4584(03)00052-9. View

5.
Uebelhart D, Thonar E, Delmas P, CHANTRAINE A, Vignon E . Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage. 1998; 6 Suppl A:39-46. DOI: 10.1016/s1063-4584(98)80011-3. View